Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation

Area of Science:

• Immunology
• Cancer Biology
• Molecular Medicine

Background:

• CD100 is an immune-activating molecule expressed on T cells.
• Antibody blockade of CD100 is a potential cancer therapy, but its effects on T cells are not well understood.
• Previous studies on anti-CD100 antibodies and T cell proliferation have yielded conflicting results.

Purpose of the Study:

• To investigate the functional effects of CD100 blockade on T cell proliferation.
• To elucidate the mechanism by which anti-CD100 antibodies affect T cells.
• To establish an in vitro system for evaluating anti-CD100 antibody efficacy and potential side effects.

Main Methods:

• Evaluation of monoclonal antibody clones against CD100.
• Assessment of T cell expansion in peripheral blood mononuclear cell and purified T cell cultures.
• Inhibition of CD100-CD72 interaction using anti-CD72 antibodies.
• Restoration of CD100-CD72 interaction using CD72-Fc.

Main Results:

• Four soluble anti-CD100 antibodies significantly reduced T cell expansion in vitro.
• Blocking the CD100-CD72 interaction with anti-CD72 antibodies mimicked the inhibitory effect of anti-CD100 antibodies.
• Restoring the CD100-CD72 interaction reversed the inhibitory effect of anti-CD100 antibodies on T cell proliferation.

Conclusions:

• T cell proliferation is regulated by the interaction between CD100 and CD72.
• Anti-CD100 antibodies inhibit T cell expansion by disrupting this interaction.
• An in vitro system was established to assess anti-CD100 antibody effects on T cells, important for clinical trial safety.